JA
Jazz Pharmaceuticals plc
JAZZ · NASDAQ
$241.31 +1.39% (+$3.30)
1M -3.19%
Market Cap $15.2B
P/E Ratio 16.11x
Div. Yield -
ROE 21.37%
Bulios Fair Price
$245.74
1.8% upside
Trenutna cena
$241.31
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica JAZZ trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
75 /100
Cheap P/E 16.11x
EV/EBITDA 12.16x
P/S 3.29x
Growth
68 /100
Growing Rev. growth 5.26%
FCF growth 18.79%
Book val. growth 11.86%
Profitability
100 /100
Strong Gross margin 84.67%
Net margin 20.45%
Op. margin 31.05%
Quality
84 /100
Excellent ROIC 18.70%
ROE 21.37%
ROA 8.49%
Debt
64 /100
Moderate Debt/Equity 0.92x
Current ratio 1.78x
Int. coverage 4.74x
Stability
39 /100
Moderate Beta 0.32x
Rev. volatility 0.75%
EPS volatility 219.02%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JAZZ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Renee D. Gala
Employees
2,890
Headquarters
Dublin
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report